Navigation Links
Black Women Have More Severe Cases of Breast Cancer Than Whites, Hispanics

Black women receiving the same breast cancer treatments as Hispanic and white women in two separate clinical trials had lower survival rates, were more likely to be diagnosed// with later-stage cancer and to have more-aggressive tumors, according to a study.

For the study, lead researcher Wendy Woodward of the University of Texas M. D. Anderson Cancer Center and colleagues examined 2,140 women participating in two clinical trials of chemotherapy for breast cancer. In both trials, researchers found that black women were more likely to have tumors that did not carry an estrogen receptor, a more aggressive type of tumor, according to Reuters. In one trial, 52% of black women survived for 10 years, compared with 62% of whites and Hispanics, while in the other trial, 40% of black women, 50% of whites and 56% of Hispanics survived for 10 years.

While further research is needed to determine why black women have lower survival rates, the researchers noted that possible contributing factors are that black women have less access to care and are more likely to be living in poverty.

In addition, the different biology of black women's tumors might account for the disparity. Woodward and her colleagues suggested more tailored treatment for black women and larger clinical trials to fully understand the disparity.

Source-Kaiser Family Foundation
'"/>




Page: 1

Related medicine news :

1. AIDS toll set to exceed Black Death
2. Black tea said to lower cholesterol
3. Women and Black Patients have less chances to survive a Heart Attack
4. Blacks decline Lung cancer surgery
5. Fewer Blacks Undergo Lung Cancer Surgery
6. Home Remedies More Used By Blacks And Native Americans
7. Black Actor Confesses Sex Cult Past
8. Malfunction Of Key Growth Factor Increases Mortality Rate From Pulmonary Fibrosis In Blacks
9. HRT elevates breast cancer risk in Black women.
10. The Naked Truth about AIDS. Advertisements Drive The Point Home in Black And White!
11. Blacks and East Asians Prone To Side Effects of Cardiovascular Drugs
Post Your Comments:
(Date:5/15/2008)...ural organic atoms with metal complexes, scientist...e of enzyme inhibitor capable of blocking a bioche...lopment. , Based on studies in human melanoma c...w ways to treat cancer by dampening the overactive...growth. , Details of the study, to be published ...
(Date:5/15/2008)...audit of community hospitals associated with Fox C... partnership between a major academic cancer cente... and community hospitals, where most care is provi...ffectively disseminating advances in cancer treatm...ive Cancer Center in Philadelphia, first establish...
(Date:5/15/2008)...he anti-inflammatory medication also known by the ...uces a specific proliferation measurement of preca...from The University of Texas M. D. Anderson Cancer...e of COX-2 inhibition toward preventing lung cance...disease. , The study is the first large randomiz...
(Date:5/15/2008)...re/ -- JumpStart Inc., the Northeast Ohio,venture ...th of innovative,early-stage businesses and ideas,...0 in CerviLenz(TM), Inc. The Cleveland-based compa...inistration cleared medical,device that allows obs...egnant women, which has been established by the Na...
Breaking Medicine News(10 mins):Health News:Novel enzyme inhibitor paves way for new cancer drug 2Health News:Novel enzyme inhibitor paves way for new cancer drug 3Health News:Partnership of academic centers and community hospitals effective model for disseminating advances 2Health News:Partnership of academic centers and community hospitals effective model for disseminating advances 3Health News:Celebrex shows benefit in first-of-its-kind lung cancer chemoprevention trial 2Health News:Celebrex shows benefit in first-of-its-kind lung cancer chemoprevention trial 3Health News:CerviLenz Receives JumpStart Investment 2Health News:CerviLenz Receives JumpStart Investment 3
...as presented yesterday at Digestive Disease Week? ... new compounds can sustain relief for these patien...flammation. These studies are conducted to review ...rome (IBS) and Crohn’s disease. They claim that th...
... obstructive pulmonary disease (COPD) are more lik...ding to a new study that is due to be presented at...rence on May 22. These differences may play a rol...female patients with COPD, said researcher Claudia...
...doctors after treating 65 million US citizens with...// to bring the blood pressure to normal range qui... clinical studies since long has shown the advanta...idker, Professor of Medicine; Brigham and Women’s ...
...nufacturing facility for the Medical Linear Accele...of Department of Information Technology (DIT). Th...ering and Research (SAMEER), an autonomous institu...lopment of an indigenous Medical LINAC, will const...
Other Medicine News:Health News:New compounds Help Sustain relief For Patients With Symptoms of Bowel Disorders 2Health News:New compounds Help Sustain relief For Patients With Symptoms of Bowel Disorders 3Health News:Lung Disease More Severe In Women Than Men 2Health News:Lung Disease More Severe In Women Than Men 3Health News:Combination Drug Therapy For Hypertension 2
(Date:5/15/2008)...A Trial data reports in third quarter ...RNewswire-FirstCall/ -- VIA Pharmaceuticals,Inc. ...on the development of,compounds for the treatment ... has completed patient enrollment in its acute cor...f three Phase 2 trials investigating VIA-2291,the...
(Date:5/15/2008)... Meeting of The American Society of Ped...INE, Calif., May 15 /- IDM ...announced the presentation of updated data,from a ...e (L-MTP-PE) in,patients with lung metastases as a... and often fatal bone tumor that typically affects...
(Date:5/14/2008)...swire-FirstCall/ -- Progen,Pharmaceuticals Limited...Company has resumed patient enrolment in the phase...polyamine analogue, PG-11047 (formerly CGC-11047),...mmenced development of PG-11047 - the lead clinica...llowing its acquisition of,Cellgate, Inc earlier t...
(Date:5/14/2008)...PacificGMP, the leader in utilizing,single-use bio...ts client,partners, announced today that it has co...ng practices) standards for a Trius Therapeutics P...orked closely with Trius on this GMP fill,project,...nd complete,within a narrow deadline," said Leigh ...
Breaking Medicine Technology:VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 2VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 3VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 4VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 5IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program 2IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program 3IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program 4IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program 5IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program 6Progen Resumes Phase 1 Development of Anti-Cancer Agent, PG-11047 2PacificGMP Completes GMP Product Fill for Trius Therapeutics 2VioQuest Pharmaceuticals to Present at BIO InvestorForum in San Francisco 1094 1VioQuest Pharmaceuticals to Present at BIO InvestorForum in San Francisco 1094 2VioQuest Pharmaceuticals to Present at BIO InvestorForum in San Francisco 1094 3Grid computing offers new hope in race against bird flu 3001 1Grid computing offers new hope in race against bird flu 3001 2Fungus genome yielding answers to protect grains people and animals 699 1Fungus genome yielding answers to protect grains people and animals 699 2Fungus genome yielding answers to protect grains people and animals 699 3The reservoir of Marburg virus identified in a species of fruit bat 697 1The reservoir of Marburg virus identified in a species of fruit bat 697 2The reservoir of Marburg virus identified in a species of fruit bat 697 3
...ed on Glucose Homeostasis Effects in,Normal and Di...-FirstCall/ -- In a 14-day,Phase IIa study of the...tional compound dapagliflozin, a selective inhibit...inistered alone or,concomitantly with metformin in...s due to adverse events and no serious adverse,eve...
.../PRNewswire/ -- Novagali Pharma, an,emerging pharm...sents positive results of its pivotal phase III cl...linical study of Vekacia(R) in,children suffering ...Afro-Asian Congress of ophthalmology (AACO) held f...KC is a severe form of chronic allergic conjunctiv...
Other Medicine Technology:First Phase II Short-Term Study on Dapagliflozin Shows Results on,Safety, Tolerability and Glycemic Markers in Subjects With Type 2,Diabetes 2First Phase II Short-Term Study on Dapagliflozin Shows Results on,Safety, Tolerability and Glycemic Markers in Subjects With Type 2,Diabetes 3First Phase II Short-Term Study on Dapagliflozin Shows Results on,Safety, Tolerability and Glycemic Markers in Subjects With Type 2,Diabetes 4First Phase II Short-Term Study on Dapagliflozin Shows Results on,Safety, Tolerability and Glycemic Markers in Subjects With Type 2,Diabetes 5First Phase II Short-Term Study on Dapagliflozin Shows Results on,Safety, Tolerability and Glycemic Markers in Subjects With Type 2,Diabetes 6Novagali Pharma Presents at AACO the Results of its Pivotal Phase,III Clinical Trial of Vekacia in Children Suffering From Vernal,Keratoconjunctivitis 2Novagali Pharma Presents at AACO the Results of its Pivotal Phase,III Clinical Trial of Vekacia in Children Suffering From Vernal,Keratoconjunctivitis 3Novagali Pharma Presents at AACO the Results of its Pivotal Phase,III Clinical Trial of Vekacia in Children Suffering From Vernal,Keratoconjunctivitis 4
Transfuse-ID™, a bedside Transfusion Verification System, is used by hospitals to ensure that a patient receives the specific unit(s) of blood that was typed and crossmatched for them. It has th
...stem helps ensure a safe care environment by autom...he unit dose level. The automated process and reli...ion and handling of all items, including vials, am...reparations and more. This saves valuable time for...
...nsfusion Safety Management system ensures your pat...care. , BloodTrack SafeTx uses the AutoPPI™ b...nt from sample collection to transfusion. SafeTx c...uces the need for bedside paperwork and associated...
wBloodCare™ provides functionality at the bedside to ensure that the correct patient receives the correct blood product.
Medicine Products: